Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18237800 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Condition: Soft Tissue Sarcomas
Interventions: Drug: Chemoradiotherapy Temozolomide;   Radiation: Proton therapy;   Procedure: Proton Chemoradiotherapy followed by surgery

Indicates status has not been verified in more than two years